Advertisement
Advertisement

NRXS

NRXS logo

Neuraxis, Inc.

7.23
USD
Sponsored
-0.28
-3.73%
Mar 26, 13:00 UTC -4
Open

NRXS Earnings Reports

Positive Surprise Ratio

NRXS beat 2 of 8 last estimates.

25%

Next Report

Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.43M
/
-$0.19
Implied change from Q4 25 (Revenue/ EPS)
+47.50%
/
+11.76%
Implied change from Q1 25 (Revenue/ EPS)
+59.38%
/
-42.42%

Neuraxis, Inc. earnings per share and revenue

On Mar 19, 2026, NRXS reported earnings of -0.17 USD per share (EPS) for Q4 25, beating the estimate of -0.21 USD, resulting in a 22.48% surprise. Revenue reached 968.13 thousand, compared to an expected 867.00 thousand, with a 11.66% difference. The market reacted with a +2.43% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 1.43 million USD, implying an increase of 11.76% EPS, and increase of 47.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-
Actual
-$0.01
Surprise
-
logo
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
logo
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
logo
Health Catalyst, Inc Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.09
Actual
$0.08
Surprise
-13.79%
logo
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
logo
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
logo
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
For Q4 2025, Neuraxis, Inc. reported EPS of -$0.17, beating estimates by 22.48%, and revenue of $968.13K, 11.66% above expectations.
The stock price moved up 2.43%, changed from $6.99 before the earnings release to $7.16 the day after.
The next earning report is scheduled for May 12, 2026.
Based on 3 analysts, Neuraxis, Inc. is expected to report EPS of -$0.19 and revenue of $1.43M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement